SCHEMBL6944873

SCHEMBL6944873

COc1ccc2c(c1)c(CCNC(=O)OC(C)(C)C)cn2N=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 6/20 0.54
MTNR1B P49286 4/20 0.54
NQO2 P16083 2/20 0.54
AKR1C3 P42330 1/20 0.47
HDAC3 O15379 3/20 0.46
HDAC6 Q9UBN7 3/20 0.46
HDAC4 P56524 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
ROCK1 Q13464 1/20 0.44
DYRK1A Q13627 1/20 0.44
PTGS2 P35354 1/20 0.43
BRD4 O60885 1/20 0.43
RAB9A P51151 2/20 0.42
KDM4E B2RXH2 1/20 0.42
NPC1 O15118 1/20 0.42
MEN1 O00255 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7122186 0.86 MTNR1A (0.55) MTNR1AMTNR1BNQO2AKR1C3HDAC3
SCHEMBL21614211 0.86 MTNR1A (0.73) MTNR1AMTNR1BNQO2AKR1C3HDAC3
SCHEMBL194360 0.86 MTNR1A (0.73) MTNR1AMTNR1BNQO2AKR1C3HDAC3
SCHEMBL6938945 0.85 MTNR1A (0.58) MTNR1AMTNR1BNQO2AKR1C3
SCHEMBL6939654 0.84 MTNR1A (0.57) MTNR1AMTNR1BNQO2AKR1C3HDAC3
SCHEMBL6944686 0.84 MTNR1A (0.57) MTNR1AMTNR1BNQO2KDM4E
SCHEMBL7437268 0.79 HTR6 (0.71) MTNR1AMTNR1B
SCHEMBL6949412 0.78 MTNR1A (0.49) MTNR1AMTNR1BNQO2AKR1C3HDAC3
SCHEMBL7134814 0.78 MTNR1A (0.61) MTNR1AMTNR1BNQO2AKR1C3HDAC3
SCHEMBL6833442 0.76 ADRB2 (0.67) MTNR1AMTNR1BNQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004085395-A1 MELATONIN DERIVATIVES AND THEIR USE FOR TREATING NEUROLOGICAL DYSFUNCTIONS FAUST PHARMACEUTICALS (FR) 2004-10-07 WO disclosed